^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    GRAIL Non-Small Cell Lung Cancer (NSCLC) ctDNA Assay

    Company:
    GRAIL
    Related tests:

    Details

    Evidence
    News
    GRAIL, Inc...today announced that the first patient has been tested for eligibility with the investigational GRAIL Non-Small Cell Lung Cancer (NSCLC) ctDNA Assay in the global TROPION-Lung12 Phase 3 study evaluating adjuvant treatment regimens in patients with Stage I adenocarcinoma NSCLC.
    Cancer:
    Non Small Cell Lung Cancer
    Method:
    blood-based methylation testing